Skip to main content
Equibles
RDNT logo

RDNT · RadNet, Inc.

Track RDNT — free Ask ALVIS about RDNT
$68.16 +1.10 (+1.64%) At close · Aug 6
Market Cap
$5.36B
Shares
78.63M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$68.16 Open$67.97 Day$66.53–68.28 52W$50.76–85.84 Avg vol 30d850K Short int10.0M · 12.8% float · 11.4d Short vol77% Last earningsMay 11, 2026 DataJan 2020–Aug 2026 Filing10-Q · May 11

Up next

Next earnings call
Aug 10, 2026 Est · unconfirmed · this week
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed May 11, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Strong Quant / Vol High
      Market backdrop VIX 15.2 · calm Equity put/call 0.60
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +3%
      above
      Price vs 50-day avg +13%
      above
      RSI (14) 63
      neutral
      MACD trend Positive
      52-week position 50%
      mid-range
      Momentum
      relative strength
      Neutral
      1-month return +3%
      trailing
      6-month return +4%
      trailing
      YTD return −4%
      this year
      Relative strength −8%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $60 › 200d $66 — 200d above 50d
      Institutional flow Accumulating
      144 of 343 funds reported for Jun 30 · net +756.1K sh shares · +18 new
      Insider flow Distributing
      Net -$3.0M over 90 days · 100% sells
      Short interest Rising
      12.76% of float · ▲ +0.3% MoM · 11.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      343 holders — near 3-yr high, broad support
      Squeeze score 77
      high risk · 0–100
      Fundamentals
      Strong
      Revenue growth +13%
      Y/Y
      EPS growth −725%
      Y/Y
      Free cash flow $224.7M
      Balance sheet $331.4M
      net debt
      Quant / Vol
      risk profile
      High
      Volatility 44%
      annualized · 1-yr
      Max drawdown −39%
      past year
      ATR 4.2%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed May 11, 2026
      Imaging Center Segment Total Net Revenue · full-year 2026 Initiated $2.36B – $2.41B
      prior FY $2.04B midpoint +16.7% Y/Y
      Digital Health Segment Total Net Revenue · full-year 2026 Initiated $135M – $145M
      prior FY $2.04B midpoint −93.1% Y/Y
      Digital Health Segment Non-Capitalized R&D - DeepHealth Cloud OS · full-year 2026 Initiated $17M – $19M
      Digital Health Segment Capital Expenditures · full-year 2026 Initiated $9M – $12M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 3 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +3% Bullish
      Price vs 50-day avg
      +13% Bullish
      RSI (14)
      63 Neutral
      MACD trend
      Positive Bullish
      52-week position
      50% Neutral
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $60 › 200d $66 — 200d above 50d
      Institutional flow Accumulating
      144 of 343 funds reported for Jun 30 · net +756.1K sh shares · +18 new
      Insider flow Distributing
      Net -$3.0M over 90 days · 100% sells
      Short interest Rising
      12.76% of float · ▲ +0.3% MoM · 11.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      343 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      52-wk low $51 Now $68 · 50% 52-wk high $86
      vs 200-day avg +3% vs 50-day avg +13%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      Adjusted Diluted Loss Per Share non-GAAP -$0.28 first quarter of 2026 —
      advanced imaging procedural volume mix 29.3% first quarter of 2026 —
      CT volume (systemwide) 17.7% first quarter of 2026 —
      MRI volume (systemwide) 20.3% first quarter of 2026 —
      outpatient imaging centers 435 first quarter of 2026 —
      Overall same-center volume 2.4% first quarter of 2026 —
      Overall volume (systemwide) 10.1% first quarter of 2026 —
      PET/CT volume (systemwide) 35.2% first quarter of 2026 —
      same-center advanced imaging procedural volumes 8.2% first quarter of 2026 —
      Same-center CT volume 4.7% first quarter of 2026 —
      Same-center PET/CT volume 14.7% first quarter of 2026 —
      Total Company Adjusted EBITDA non-GAAP $63.3M first quarter of 2026 —
      Total Company Adjusted Loss non-GAAP -$21.6M first quarter of 2026 —
      Adjusted Earnings Per Share non-GAAP $0.23 Q4 2025 —
      Adjusted EBITDA non-GAAP $300.2M FY2025 —
      CT volume growth 10.3% Q4 2025 —
      MRI volume growth 15.8% Q4 2025 —
      PET/CT volume growth 28.3% Q4 2025 —
      Same-center CT volume growth 6.3% Q4 2025 —
      Same-center MRI volume growth 11.4% Q4 2025 —
      Same-center overall volume growth 4.5% Q4 2025 —
      Same-center PET/CT volume growth 14.3% Q4 2025 —

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Diagnostics & Research — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      RDNT
      RadNet, Inc.
      this stock
      		$5.36B -4.5% +13.0% — 12.8%
      TMO
      Thermo Fisher Scientific Inc.
      		 $214.46B +0.3% +0.4% 31.2 1.4%
      DHR
      Danaher Corp /De/
      		 $140.58B -12.3% +8.5% 35.5 1.4%
      IDXX
      Idexx Laboratories Inc /De
      		 $46.48B -12.8% +10.4% 41.5 2.7%
      A
      Agilent Technologies, Inc.
      		 $39.92B +4.5% +6.4% 28.4 2.7%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      342
      % held
      94.3%
      Reported
      144 of 343
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      385
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      10.0M
      Days to cover
      11.4d
      Change
      +32.6K sh
      View
      Short Volume
      Short vol %
      77%
      As of
      Aug 6, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      6
      Value
      $407
      As of
      Jul 8, 2026
      View
      Off-Exchange
      Off-exchange %
      39.3%
      Week of
      Jun 29, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$3.0M
      Buyers / Sellers
      0 / 3
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $2.0B
      Net income (FY)
      $-18.7M
      EPS diluted
      $-0.25
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jun 10, 2026
      This year
      11
      View
      Proposed Sales
      Value
      $145.4K
      Shares
      2.7K
      Filed
      Jun 18, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      May 11, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      RDNT +8.7% +3.4% +4.5% +6.9% -4.5%
      SPY +3.6% +2.2% +12.8% +2.9% +12.7%
      vs SPY +5.1% +1.1% -8.3% +4.0% -17.2%
      Key facts CIK 790526 CUSIP 750491102 13F (30d) 129 filings 121 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)